Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Span of Spleen Is Associated With Disability Status in Multiple Sclerosis: A Cross-Sectional Abdominopelvic Ultrasonography Study
Vahid Shaygannejad
Vahid Shaygannejad

Professor of Neurology

Department of Neurology, School of Medicine

Neurosciences Research Center

Kashani Hospital

Isfahan University of Medical Sciences

All Documents
1. Investigating the Safety of Fampridine in Patients With Different Stages of Multiple Sclerosis, International Journal of Preventive Medicine (2025)
2. A National Registry-Based Study of Ethnic Differences in People With Multiple Sclerosis in Iran, Clinical Neurology and Neurosurgery (2024)
3. A National Registry-Based Study of Ethnic Differences in People With Multiple Sclerosis in Iran, Clinical Neurology and Neurosurgery (2024)
4. Asthma and Chronic Obstructive Pulmonary Disease (Copd) in People With Multiple Sclerosis: A Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2024)
5. Concurrent Glioma and Multiple Sclerosis: A Systematic Review of Case Reports, Multiple Sclerosis and Related Disorders (2024)
6. Dysphagia in Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: A Comparison of Frequency, Severity, and Effects on Quality of Life, Multiple Sclerosis and Related Disorders (2024)
7. Early Clinical Response and Complications of Therapeutic Plasma Exchange in Central Nervous System Demyelinating Diseases, Journal of Central Nervous System Disease (2024)
8. Effectiveness of Schema Therapy on Anxiety, Depression, Fatigue, Quality of Life, and Sleep in Patients With Multiple Sclerosis: A Randomized Controlled Trial, Middle East Journal of Rehabilitation and Health Studies (2024)
9. Examining the Environmental Risk Factors of Progressive-Onset and Relapsing-Onset Multiple Sclerosis: Recruitment Challenges, Potential Bias, and Statistical Strategies, Journal of Neurology (2024)
10. Insights Into the Interplay Between Epstein-Barr Virus (Ebv) and Multiple Sclerosis (Ms): A State-Of-The-Art Review and Implications for Vaccine Development, Health Science Reports (2024)
11. Insights Into the Interplay Between Epstein-Barr Virus (Ebv) and Multiple Sclerosis (Ms): A State-Of-The-Art Review and Implications for Vaccine Development, Health Science Reports (2024)
12. Interdependency of Ninj2 Gene Expression and Polymorphism With Susceptibility and Response to Interferon Beta in Patients With Multiple Sclerosis, International Journal of Neuroscience (2024)
13. Investigation of the Effects of Cocoa Powder on Fatigue Severity in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Controlled Trial, Clinical Nutrition Open Science (2024)
14. Multiple Sclerosis and Personality Traits: Associations With Depression and Anxiety, European Journal of Medical Research (2024)
15. Onabotulinum Toxin a Improves Neurogenic Detrusor Overactivity Following Spinal Cord Injury: A Systematic Review and Meta-Analysis, Spinal Cord (2024)
16. Prevalence and Incidence of Multiple Sclerosis in Isfahan, Iran Between 1996 and 2021: A Population-Based Study, Multiple Sclerosis and Related Disorders (2024)
17. Safety and Efficacy of Covid-19 Vaccines Among Patients With Multiple Sclerosis: Letter to Editor, International Journal of Preventive Medicine (2024)
18. Validity and Reliability of the Persian Version of Recce Stigma Scale in People With Multiple Sclerosis and Its Impact on Quality of Life, BMC Neurology (2024)
19. Validity and Reliability of the Persian Version of Recce Stigma Scale in People With Multiple Sclerosis and Its Impact on Quality of Life, BMC Neurology (2024)
20. A Mechanistic Insight Into Sources of Error of Visual Working Memory in Multiple Sclerosis, eLife (2023)
21. Assessment of Intelligence Quotient in Patients With Neuromyelitis Optica Spectrum Disease and Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2023)
22. Association Between Helicobacter Pylori Infection and Seronegative Neuromyelitis Optica Spectrum Disorder, Caspian Journal of Neurological Sciences (2023)
23. Cns Demyelinating Disease Following Inactivated or Viral Vector Sars-Cov-2 Vaccines: A Case Series, Vaccine (2023)
24. Comparative Effectiveness in Multiple Sclerosis: A Methodological Comparison, Multiple Sclerosis Journal (2023)
25. Comparing the Hippocampal Volumetric Atrophy Between Demented and Nondemented Individuals With Parkinson's Disease: A Systematic Review and Meta-Analysis, Health Science Reports (2023)
26. Demographic and Clinical Characteristics of Familial and Sporadic Multiple Sclerosis Patients, International Journal of Preventive Medicine (2023)
27. Disability Accrual in Primary and Secondary Progressive Multiple Sclerosis, Journal of Neurology, Neurosurgery and Psychiatry (2023)
28. Early Non-Disabling Relapses Are Important Predictors of Disability Accumulation in People With Relapsing-Remitting Multiple Sclerosis, Multiple Sclerosis Journal (2023)
29. Editorial: Cns Autoimmune Disorders and Covid-19, Frontiers in Neurology (2023)
30. Effect of Deep Gray Matter Atrophy on Information Processing Speed in Early Relapsing-Remitting Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2023)
31. Effectiveness of Bbibp-Corv Vaccine in Preventing Sars-Cov2 Infection and Severe Outcomes in People Living With Multiple Sclerosis: A Population-Based Study, Multiple Sclerosis and Related Disorders (2023)
32. Effectiveness of Multiple Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis: Causal Inference to Emulate a Multiarm Randomised Trial, Journal of Neurology, Neurosurgery and Psychiatry (2023)
33. Emotional Competencies in Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2023)
34. External Validation of a Clinical Prediction Model in Multiple Sclerosis, Multiple Sclerosis Journal (2023)
35. Fear of Re-Infection, Relapse, and Anxiety During Covid-19 Pandemic in Patients With Multiple Sclerosis: A Multi-Center Study, Current Journal of Neurology (2023)
36. Fear of Re-Infection, Relapse, and Anxiety During Covid-19 Pandemic in Patients With Multiple Sclerosis: A Multi-Center Study, Current Journal of Neurology (2023)
37. Late-Onset Multiple Sclerosis in Iran: A Report on Demographic and Disease Characteristics, Multiple Sclerosis and Related Disorders (2023)
38. Late-Onset Multiple Sclerosis in Iran: A Report on Demographic and Disease Characteristics, Multiple Sclerosis and Related Disorders (2023)
39. Multiple Sclerosis (Ms) and Neuromyelitis Optica Spectrum Disorder (Nmosd) Following Covid-19 Vaccines: A Systematic Review, Revue Neurologique (2023)
40. Multiple Sclerosis and the Incidence of Venous Thromboembolism: A Systematic Review and Meta-Analysis, Journal of Thrombosis and Thrombolysis (2023)
41. Multiple Sclerosis Is Associated With Worse Covid-19 Outcomes Compared to the General Population: A Population-Based Study, Multiple Sclerosis and Related Disorders (2023)
42. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and Covid-19: A Systematic Review, Journal of Central Nervous System Disease (2023)
43. Patterns of Attention Deficit in Relapsing and Progressive Phenotypes of Multiple Sclerosis, Scientific Reports (2023)
44. Predictors of Treatment Switching in the Big Multiple Sclerosis Data Network, Frontiers in Neurology (2023)
45. Presentation of Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (Cadasil) in the Acute Phase of Covid-19 Infection, Journal of Clinical Neurology (Korea) (2023)
46. Prevalence of Dysphagia in Patients With Multiple Sclerosis: A Systematic Review and Meta-Analysis, Journal of Clinical Neuroscience (2023)
47. Safety and Effectiveness of Cinnomer® on Disease Characteristics, Depression, and Quality of Life of Patients With Multiple Sclerosis: A Phase Iv, Post-Marketing, Prospective, Multicenter Study, Archives of Iranian Medicine (2023)
48. Safety and Effectiveness of Cinnomer® on Disease Characteristics, Depression, and Quality of Life of Patients With Multiple Sclerosis: A Phase Iv, Post-Marketing, Prospective, Multicenter Study, Archives of Iranian Medicine (2023)
49. Sex Differences in Cerebral Venous Sinus Thrombosis After Adenoviral Vaccination Against Covid-19, European Stroke Journal (2023)
50. Social Support and Anxiety Correlation With Resilience in Patients With Multiple Sclerosis During Covid-19 Pandemic, Current Journal of Neurology (2023)
51. Thalamic Asymmetry in Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2023)
52. The Association Between Multiple Sclerosis and Migraine: A Meta-Analysis, Multiple Sclerosis and Related Disorders (2023)
53. The Association Between Multiple Sclerosis and Migraine: A Meta-Analysis, Multiple Sclerosis and Related Disorders (2023)
54. Variability of the Response to Immunotherapy Among Subgroups of Patients With Multiple Sclerosis, European Journal of Neurology (2023)
55. Working Memory Dysfunction Differs Between Secondary Progressive and Relapsing Multiple Sclerosis: Effects of Clinical Phenotype, Age, Disease Duration, and Disability, Multiple Sclerosis and Related Disorders (2023)
56. Worldwide Prevalence of Neuromyelitis Optica Spectrum Disorder (Nmosd) and Neuromyelitis Optica (Nmo): A Systematic Review and Meta-Analysis, Neurological Sciences (2023)
57. Abrupt Bilateral Blindness As a Rare Post-Acute Demyelinating Consequence of Covid-19, eNeurologicalSci (2022)
58. Association of Exposure to Particulate Matters and Multiple Sclerosis: A Systematic Review and Meta-Analysis, NeuroImmunoModulation (2022)
59. Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis: An International Registry Study, Neurology (2022)
60. Autoimmune Hemolytic Anemia After Treatment With Fingolimod in a Patient With Multiple Sclerosis (Ms): A Case Report and Review of the Literature, Autoimmunity Reviews (2022)
61. Characteristics of Covid-19 in Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)
62. Characteristics of Covid-19 in Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)
63. Comparison of Disability in Patients With Multiple Sclerosis With and Without Familial History, Journal of Isfahan Medical School (2022)
64. Comparison of Follicular T Helper Cells, Monocytes, and T Cells Priming Between Newly Diagnosed and Rituximab-Treated Ms Patients and Healthy Controls, Research in Pharmaceutical Sciences (2022)
65. Comparison of Follicular T Helper Cells, Monocytes, and T Cells Priming Between Newly Diagnosed and Rituximab-Treated Ms Patients and Healthy Controls, Research in Pharmaceutical Sciences (2022)
66. Confirmed Disability Progression As a Marker of Permanent Disability in Multiple Sclerosis, European Journal of Neurology (2022)
67. Corrigendum to Longitudinal Machine Learning Modeling of Ms Patient Trajectories Improves Predictions of Disability Progression: (Computer Methods and Programs in Biomedicine (2021) 208, (S0169260721002546), (10.1016/J.Cmpb.2021.106180)), Computer Methods and Programs in Biomedicine (2022)
68. Covid-19 Infection and Hospitalization Rate in Iranian Multiple Sclerosis Patients: What We Know by May 2021, Multiple Sclerosis and Related Disorders (2022)
69. Covid-19 Susceptibility and Outcomes Among Patients With Neuromyelitis Optica Spectrum Disorder (Nmosd): A Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2022)
70. Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis, Neurology (2022)
71. Effects of Acceptance and Commitment Therapy (Act) and Mindfulness-Based Stress Reduction (Mbsr) on Symptoms and Emotional Competencies in Individuals With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)
72. Ermin Deficiency Leads to Compromised Myelin, Inflammatory Milieu, and Susceptibility to Demyelinating Insult, Brain Pathology (2022)
73. Fulminant Neuromyelitis Optica Spectrum Disorder (Nmosd) Following Covid-19 Vaccination: A Need for Reconsideration?, Multiple Sclerosis and Related Disorders (2022)
74. Hearing Loss Among Patients With Multiple Sclerosis (Pwms): A Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2022)
75. Impact of Methodological Choices in Comparative Effectiveness Studies: Application in Natalizumab Versus Fingolimod Comparison Among Patients With Multiple Sclerosis, BMC Medical Research Methodology (2022)
76. Incidence of Cancer in Patients With Multiple Sclerosis (Ms) Who Were Treated With Fingolimod: A Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2022)
77. Incidence of Cancer in Patients With Multiple Sclerosis (Ms) Who Were Treated With Fingolimod: A Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2022)
78. Incidence, Prevalence, and Characteristics of Heart Failure Among Patients With Multiple Sclerosis: A Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2022)
79. Is Myasthenia Gravis a Real Complication of the Covid-19 Vaccine? a Case Report-Based Systematic Review, Canadian Journal of Infectious Diseases and Medical Microbiology (2022)
80. Mizaj Assessment in Multiple Sclerosis (Ms) Patients Based on Persian Medicine, Journal of Complementary and Integrative Medicine (2022)
81. Multiple Sclerosis Severity Score (Msss) Improves the Accuracy of Individualized Prediction in Ms, Multiple Sclerosis Journal (2022)
82. Olfactory Dysfunction in Patients With Multiple Sclerosis; a Systematic Review and Meta-Analysis, PLoS ONE (2022)
83. Outcomes of Cerebral Venous Thrombosis Due to Vaccine-Induced Immune Thrombotic Thrombocytopenia After the Acute Phase, Stroke (2022)
84. Persistent Cognitive Impairment As a Rare Manifestation of Mild Covid-19 Infection – a Case Series, Romanian Journal of Neurology/ Revista Romana de Neurologie (2022)
85. Post Covid-19 Infection Neuromyelitis Optica Spectrum Disorder (Nmosd): A Case Report-Based Systematic Review, Multiple Sclerosis and Related Disorders (2022)
86. Predictors of Catching Covid-19 Infection During Pandemic Stage in Patients With Multiple Sclerosis (Ms), International Journal of Preventive Medicine (2022)
87. Predictors of Catching Covid-19 Infection During Pandemic Stage in Patients With Multiple Sclerosis (Ms), International Journal of Preventive Medicine (2022)
88. Prevalence and Risk Factors of Dysphagia in Patients With Multiple Sclerosis, Dysphagia (2022)
89. Prevalence of Multiple Sclerosis (Ms) in Iran: A Systematic Review and Meta-Analysis, Neurological Sciences (2022)
90. Prevalence of Multiple Sclerosis (Ms) in Iran: A Systematic Review and Meta-Analysis, Neurological Sciences (2022)
91. Prevalence of Trigeminal Neuralgia in Multiple Sclerosis: A Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2022)
92. Prevalence of Trigeminal Neuralgia in Multiple Sclerosis: A Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2022)
93. Psychometric Assessment of the Persian Version of the Patient Determined Disease Steps Scale in Patients With Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder, Current Journal of Neurology (2022)
94. Psychometric Assessment of the Persian Version of the Patient Determined Disease Steps Scale in Patients With Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder, Current Journal of Neurology (2022)
95. Psychometric Properties of the Persian Version of the Multiple Sclerosis Work Difficulties Questionnaire (Mswdq) Questionnaire, International Journal of Preventive Medicine (2022)
96. Psychometric Properties of the Persian Version of the Multiple Sclerosis Work Difficulties Questionnaire (Mswdq) Questionnaire, International Journal of Preventive Medicine (2022)
97. Radiologically Isolated Syndrome: An Atypical Presentation of Balo's Concentric Sclerosis in a Patient With the Meniere's Disease, Neurology India (2022)
98. Risk and Severity of Sars-Cov-2 Reinfection Among Patients With Multiple Sclerosis Vs. the General Population: A Population-Based Study, BMC Neurology (2022)
99. Safety of Sinopharm Vaccine for People With Multiple Sclerosis: Study of Adverse Reactions and Disease Activity, Multiple Sclerosis and Related Disorders (2022)
100. Sexual Dysfunction in Women With Neuromyelitis Optica Spectrum Disorders and Multiple Sclerosis, Sexuality and Disability (2022)
101. Short Report: Assessment of Coping Strategies in Patients With Neuromyelitis Optica Spectrum Disorder (Nmosd) and Multiple Sclerosis, Psychology, Health and Medicine (2022)
102. Sociodemographic and Illness-Related Indicators to Predict the Status of Neuromyelitis Optica Spectrum Disorder (Nmosd) Five Years After Disease Onset, Journal of Clinical Medicine (2022)
103. Sociodemographic and Illness-Related Indicators to Predict the Status of Neuromyelitis Optica Spectrum Disorder (Nmosd) Five Years After Disease Onset, Journal of Clinical Medicine (2022)
104. Study of the Correlation Between Mir-106A, Mir-125B, and Mir-330 on Multiple Sclerosis Patients by Targeting Tnfsf4 and Sp1 in Nf-Κb/Tnf-Α Pathway: A Case-Control Study, Cell Journal (2022)
105. The Effect of Interferon-Beta Therapy on T-Helper 17/Mir-326 and T-Helper 1/Mir-29B-3P Axis in Relapsing-Remitting Multiple Sclerosis Patients, NeuroImmunoModulation (2022)
106. The Effects of Garlic Extract on Il-17A Il-17F and Ifnγ Mrna Expression in Peripheral Blood Mononuclear Cells of Multiple Sclerosis Patients, Journal of Isfahan Medical School (2022)
107. The Efficacy of Transdiagnostic Cognitive Behavioral Therapy on Migraine Headache: A Pilot, Feasibility Study, BMC Neurology (2022)
108. The Role of Cobalamin on Interleukin 10, Osteopontin, and Related Micrornas in Multiple Sclerosis, Iranian Journal of Allergy, Asthma and Immunology (2022)
109. Acute Cns Demyelination in a Subject With Cerebellar Ataxia Following the First Dose of Covid-19 Vaccine; a Case Report, Human Vaccines and Immunotherapeutics (2021)
110. Assessment of Mental Health, Knowledge, and Attitude of Patients With Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder in Response to 2019 Novel Coronavirus, Neurological Sciences (2021)
111. Can Coronavirus Disease 2019 (Covid-19) Trigger Exacerbation of Multiple Sclerosis? a Retrospective Study, Multiple Sclerosis and Related Disorders (2021)
112. Comparable Efficacy and Safety of Teriflunomide Versus Dimethyl Fumarate for the Treatment of Relapsing-Remitting Multiple Sclerosis, Neurology Research International (2021)
113. Comparable Efficacy and Safety of Teriflunomide Versus Dimethyl Fumarate for the Treatment of Relapsing-Remitting Multiple Sclerosis, Neurology Research International (2021)
114. Comparison of Susceptibility Weighted Imaging With Conventional Mri Sequences in Multiple Sclerosis Plaque Assessment: A Cross-Sectional Study, Journal of Research in Medical Sciences (2021)
115. Covid-19 Among Patients With Multiple Sclerosis a Systematic Review, Neurology: Neuroimmunology and NeuroInflammation (2021)
116. Covid-19 Among Patients With Multiple Sclerosis a Systematic Review, Neurology: Neuroimmunology and NeuroInflammation (2021)
117. Disability Outcomes of Early Cerebellar and Brainstem Symptoms in Multiple Sclerosis, Multiple Sclerosis Journal (2021)
118. Early Predictors of Conversion to Secondary Progressive Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2021)
119. Early Predictors of Conversion to Secondary Progressive Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2021)
120. Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years, Neurology (2021)
121. Effectiveness of Bupropion on Sexual Dysfunction of Women With Multiple Sclerosis: A Clinical Trial, Iranian Journal of Obstetrics, Gynecology and Infertility (2021)
122. Efficacy and Safety of Rituximab in Treating Patients With Neuromyelitis Optica Spectrum Disorder (Nmosd): A Systematic Review and Meta-Analysis, Autoimmunity Reviews (2021)
123. Efficacy and Safety of Rituximab in Treating Patients With Neuromyelitis Optica Spectrum Disorder (Nmosd): A Systematic Review and Meta-Analysis, Autoimmunity Reviews (2021)
124. Expression and Clinical Significance of Il7r, Nfatc2, and Rnf213 in Familial and Sporadic Multiple Sclerosis, Scientific Reports (2021)
125. Fear of Relapse, Social Support, and Psychological Well-Being (Depression, Anxiety, and Stress Level) of Patients With Multiple Sclerosis (Ms) During the Covid-19 Pandemic Stage, Neurological Sciences (2021)
126. Fear of Relapse, Social Support, and Psychological Well-Being (Depression, Anxiety, and Stress Level) of Patients With Multiple Sclerosis (Ms) During the Covid-19 Pandemic Stage, Neurological Sciences (2021)
127. Frequency of Comorbidities in Neuromyelitis Optica Spectrum Disorder, Multiple Sclerosis and Related Disorders (2021)
128. Gene Expression Profiles of Yap1, Taz, Crb3, and Vdr in Familial and Sporadic Multiple Sclerosis Among an Iranian Population, Scientific Reports (2021)
129. High Prevalence of Mmp9 −1562C/T Gene Polymorphism in an Iranian Population of Neuromyelitis Optica, a Pilot Study, Gene Reports (2021)
130. Longitudinal Machine Learning Modeling of Ms Patient Trajectories Improves Predictions of Disability Progression, Computer Methods and Programs in Biomedicine (2021)
131. Managing Anxiety Among Multiple Sclerosis Patients During Covid-19 Pandemic, Journal of Research in Medical Sciences (2021)
132. Mizaj Assessment in Multiple Sclerosis (Ms) Patients Based on Persian Medicine, Journal of Complementary and Integrative Medicine (2021)
133. Modulation of Th17 Proliferation and Il-17A Gene Expression by Acetylated Form of Apigenin in Patients With Multiple Sclerosis, Immunological Investigations (2021)
134. Paraparesis Due to Aortic Thromboembolism As a Rare Complication of Covid-19 Infection, Journal of Vascular Surgery (2021)
135. Pregnancy Outcome in Patients With Multiple Sclerosis Treated With Rituximab: A Case-Series Study, Multiple Sclerosis and Related Disorders (2021)
136. Pregnancy Outcome in Patients With Multiple Sclerosis Treated With Rituximab: A Case-Series Study, Multiple Sclerosis and Related Disorders (2021)
137. Pregnancy Outcome in Patients With Neuromyelitis Optica Spectrum Disorder Treated With Rituximab: A Case-Series Study, Caspian Journal of Internal Medicine (2021)
138. Pregnancy Outcome in Patients With Neuromyelitis Optica Spectrum Disorder Treated With Rituximab: A Case-Series Study, Caspian Journal of Internal Medicine (2021)
139. Prevalence of Seizure/Epilepsy in Patients With Multiple Sclerosis: A Systematic Review and Meta-Analysis, International Journal of Preventive Medicine (2021)
140. Prevalence of Seizure/Epilepsy in Patients With Multiple Sclerosis: A Systematic Review and Meta-Analysis, International Journal of Preventive Medicine (2021)
141. Research Paper: Anti-Myelin Oligodendrocyte Glycoprotein in Aquaporin-4 Negative Neuromyelitis Optica Spectrum Disorder, Caspian Journal of Neurological Sciences (2021)
142. Rituximab and Glatiramer Acetate in Secondary Progressive Multiple Sclerosis: A Randomized Clinical Trial, Acta Neurologica Scandinavica (2021)
143. Safety and Efficacy of Fingolimod in Iranian Patients With Relapsing-Remitting Multiple Sclerosis: An Open-Label Study, Caspian Journal of Internal Medicine (2021)
144. Safety and Efficacy of Fingolimod in Iranian Patients With Relapsing-Remitting Multiple Sclerosis: An Open-Label Study, Caspian Journal of Internal Medicine (2021)
145. Significant Immunomodulatory and Hepatoprotective Impacts of Silymarin in Ms Patients: A Double-Blind Placebo-Controlled Clinical Trial, International Immunopharmacology (2021)
146. Significant Immunomodulatory and Hepatoprotective Impacts of Silymarin in Ms Patients: A Double-Blind Placebo-Controlled Clinical Trial, International Immunopharmacology (2021)
147. The Effect of Emotional Freedom Technique on Fatigue Among Women With Multiple Sclerosis: A Randomized Controlled Trial, Iranian Journal of Nursing and Midwifery Research (2021)
148. The Effectiveness of Natalizumab Vs Fingolimod–A Comparison of International Registry Studies, Multiple Sclerosis and Related Disorders (2021)
149. The Prevalence of Myocardial Infarction Among Multiple Sclerosis Patients: A Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2021)
150. The Prevalence of Myocardial Infarction Among Multiple Sclerosis Patients: A Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2021)
151. The Serum Level of Midkine in Patients With Multiple Sclerosis and Neuromyelitis Optica, Basic and Clinical Neuroscience (2021)
152. Utilization of Multiple Sclerosis Therapies in the Middle East Over a Decade: 2009–2018, CNS Drugs (2021)
153. Vitamin D Level in Iranian Patients With Neuromyelitis Optica, Journal of Isfahan Medical School (2021)
154. Association of Helicobacter Pylori With Multiple Sclerosis: Protective or Risk Factor?, Current Journal of Neurology (2020)
155. Characteristics of Covid-19 Disease in Multiple Sclerosis Patients, Multiple Sclerosis and Related Disorders (2020)
156. Characteristics of Covid-19 Disease in Multiple Sclerosis Patients, Multiple Sclerosis and Related Disorders (2020)
157. Clinical Characteristics and Disability Progression of Early-And Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis, Journal of Clinical Medicine (2020)
158. Clinical Characteristics and Disability Progression of Early-And Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis, Journal of Clinical Medicine (2020)
159. Comparison of Cognitive Rehabilitation Versus Donepezil Therapy on Memory Performance, Attention, Quality of Life, and Depression Among Multiple Sclerosis Patients, Neurology Research International (2020)
160. Comparison of Expression Levels of Mir-29B-3P and Mir-326 in T Helper-1 and T Helper-17 Cells Isolated From Responsive and Non-Responsive Relapsing-Remitting Multiple Sclerosis Patients Treated With Interferon-Beta, Iranian Journal of Allergy, Asthma and Immunology (2020)
161. Comparison of Prevalence Rates of Restless Legs Syndrome, Self-Assessed Risks of Obstructive Sleep Apnea, and Daytime Sleepiness Among Patients With Multiple Sclerosis (Ms), Clinically Isolated Syndrome (Cis) and Neuromyelitis Optica Spectrum Disorder (Nmosd), Sleep Medicine (2020)
162. Comparison of Prevalence Rates of Restless Legs Syndrome, Self-Assessed Risks of Obstructive Sleep Apnea, and Daytime Sleepiness Among Patients With Multiple Sclerosis (Ms), Clinically Isolated Syndrome (Cis) and Neuromyelitis Optica Spectrum Disorder (Nmosd), Sleep Medicine (2020)
163. Comparison of Psychological Difficulties in Patients With Migraine and Epilepsy Using Paradise-24 Questionnaire, Journal of Multidisciplinary Healthcare (2020)
164. Comparison of Psychological Difficulties in Patients With Migraine and Epilepsy Using Paradise-24 Questionnaire, Journal of Multidisciplinary Healthcare (2020)
165. Comparison of the Expression of Mir-326 Between Interferon Beta Responders and Non-Responders in Relapsing-Remitting Multiple Sclerosis, Cell Journal (2020)
166. Covid-19 Infection in a Patient With Multiple Sclerosis Treated With Fingolimod, Neurology: Neuroimmunology and NeuroInflammation (2020)
167. Effect of Donepezil on Cognitive Impairment, Quality of Life, and Depression in Multiple Sclerosis Patients: A Randomized Clinical Trial, International Journal of Preventive Medicine (2020)
168. Favorable Outcome After Covid-19 Infection in a Multiple Sclerosis Patient Initiated on Ocrelizumab During the Pandemic, Multiple Sclerosis and Related Disorders (2020)
169. Favorable Outcome After Covid-19 Infection in a Multiple Sclerosis Patient Initiated on Ocrelizumab During the Pandemic, Multiple Sclerosis and Related Disorders (2020)
170. Higher Disease and Pain Severity and Fatigue and Lower Balance Skills Are Associated With Higher Prevalence of Falling Among Individuals With the Inflammatory Disease of Neuromyelitis Optica Spectrum Disorder (Nmosd), Journal of Clinical Medicine (2020)
171. Higher Disease and Pain Severity and Fatigue and Lower Balance Skills Are Associated With Higher Prevalence of Falling Among Individuals With the Inflammatory Disease of Neuromyelitis Optica Spectrum Disorder (Nmosd), Journal of Clinical Medicine (2020)
172. Immune Reconstitution Therapy or Continuous Immunosuppression for the Management of Active Relapsing–Remitting Multiple Sclerosis Patients? a Narrative Review, Neurology and Therapy (2020)
173. Immune Reconstitution Therapy or Continuous Immunosuppression for the Management of Active Relapsing–Remitting Multiple Sclerosis Patients? a Narrative Review, Neurology and Therapy (2020)
174. Is Fertility Affected in Women of Childbearing Age With Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder?, Journal of Molecular Neuroscience (2020)
175. Ms Care in Novel Coronavirus 19 Pandemic, International Journal of Preventive Medicine (2020)
176. Pre-Pregnancy, Obstetric and Delivery Status in Women With Neuromyelitis Optica Spectrum Disorder, Multiple Sclerosis and Related Disorders (2020)
177. Progressive Multifocal Leukoencephalopathy As the First Manifestation of Aids: A Rare Case Report, Archives of Clinical Infectious Diseases (2020)
178. Progressive Multifocal Leukoencephalopathy As the First Manifestation of Aids: A Rare Case Report, Archives of Clinical Infectious Diseases (2020)
179. Quality of Life Among Patients With Multiple Sclerosis and Voiding Dysfunction: A Cross-Sectional Study, BMC Urology (2020)
180. Screening Neuromyelitis Optica Patients for Covid-19 Infection, Autoimmunity Reviews (2020)
181. Screening Neuromyelitis Optica Patients for Covid-19 Infection, Autoimmunity Reviews (2020)
182. Sexual Dysfunction in Women With Multiple Sclerosis: Prevalence and Impact on Quality of Life, BMC Urology (2020)
183. Spiritual Health in Women With Multiple Sclerosis and Its Association With Self-Esteem, Journal of Education and Health Promotion (2020)
184. The Prevalence of Lower Urinary Tract Symptoms Based on Individual and Clinical Parameters in Patients With Multiple Sclerosis, BMC Neurology (2020)
185. The Prevalence of Migraine in Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis, Journal of Clinical Neuroscience (2020)
186. The Prevalence of Migraine in Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis, Journal of Clinical Neuroscience (2020)
187. Therapeutic Plasma Exchange May Adjust Il-6 and Tgf-Β Signals in Relapsed Ms Patients Peripheral Blood, Journal of Clinical Apheresis (2020)
188. Upregulation of Mtor, Rps6kb1, and Eif4ebp1 in the Whole Blood Samples of Iranian Patients With Multiple Sclerosis Compared to Healthy Controls, Metabolic Brain Disease (2020)
189. Upregulation of Mtor, Rps6kb1, and Eif4ebp1 in the Whole Blood Samples of Iranian Patients With Multiple Sclerosis Compared to Healthy Controls, Metabolic Brain Disease (2020)
190. ‘I Want to Be With You, But I Have Ms’: Challenges of Interpersonal Relationships From the Ms Patients’ Point of View, Health and Social Care in the Community (2020)
191. Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis, JAMA - Journal of the American Medical Association (2019)
192. Case Report: Tumefactive Brain Lesions in Patients With Neuromyelitis Optica Spectrum Disorder, Caspian Journal of Neurological Sciences (2019)
193. Comparison of Fingolimod, Dimethyl Fumarate and Teriflunomide for Multiple Sclerosis, Journal of Neurology, Neurosurgery and Psychiatry (2019)
194. Comparison of Sleep Complaints and Quality of Life Between Patients With Neuromyelitis Optica Spectrum Disorder (Nmosd) and Healthy Controls, Multiple Sclerosis and Related Disorders (2019)
195. Disease Course, Progression and Activity of Neuromyelitis Optica (Nmosd) in Patients Who Were Treated With Rituximab, 6 and 12 Months After Receiving the First Dose of Drug, in Isfahan City, Multiple Sclerosis and Related Disorders (2019)
196. Elevated Serum Level of Il-4 in Neuromyelitis Optica and Multiple Sclerosis Patients, Journal of Immunoassay and Immunochemistry (2019)
197. Elevated Serum Level of Il-4 in Neuromyelitis Optica and Multiple Sclerosis Patients, Journal of Immunoassay and Immunochemistry (2019)
198. Evaluation of Cognitive Rehabilitation on the Cognitive Performance in Multiple Sclerosis: A Randomized Controlled Trial, Journal of Research in Medical Sciences (2019)
199. Expression of Ox40 Gene and Its Serum Levels in Neuromyelitis Optica Patients, Biomolecular Concepts (2019)
200. Immunoregulatory Effects of Silymarin on Proliferation and Activation of Th1 Cells Isolated From Newly Diagnosed and Ifn-ß 1B -Treated Ms Patients, Inflammation (2019)
201. In Patients With Multiple Sclerosis, Both Objective and Subjective Sleep, Depression, Fatigue, and Paresthesia Improved After 3 Weeks of Regular Exercise, Frontiers in Psychiatry (2019)
202. Long-Term Tolerability, Safety and Efficacy of Rituximab in Neuromyelitis Optica Spectrum Disorder: A Prospective Study, Journal of Neurology (2019)
203. Management of Seizures in Patients With Multiple Sclerosis; an Iranian Consensus, Epilepsy and Behavior (2019)
204. Management of Seizures in Patients With Multiple Sclerosis; an Iranian Consensus, Epilepsy and Behavior (2019)
205. Microrna-29B Variants and Mxa Expression Change During Interferon Beta Therapy in Patients With Relapsing-Remitting Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2019)
206. Microrna-29B Variants and Mxa Expression Change During Interferon Beta Therapy in Patients With Relapsing-Remitting Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2019)
207. Novel Mutation in Htra1 in a Family With Diffuse White Matter Lesions and Inflammatory Features, Neurology: Genetics (2019)
208. Novel Mutation in Htra1 in a Family With Diffuse White Matter Lesions and Inflammatory Features, Neurology: Genetics (2019)
209. Research Paper: Assessment the Possible Association Between Neuromyelitis Optica and Cytomegalovirus As a Provocative Factor, Caspian Journal of Neurological Sciences (2019)
210. Research Paper: Comparison of Bladder Dysfunction and Urinary Symptoms Between Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder, Caspian Journal of Neurological Sciences (2019)
211. Silymarin Restores Regulatory T Cells (Tregs) Function in Multiple Sclerosis (Ms) Patients in Vitro, Inflammation (2019)
212. Association Between Sun Exposure, Vitamin D Intake, Serum Vitamin D Level, and Immunoglobulin G Level in Patients With Neuromyelitis Optica Spectrum Disorder, International Journal of Preventive Medicine (2018)
213. Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple Sclerosis, JAMA Neurology (2018)
214. Comparative Study of Quality of Life, Anxiety, Depression, and Fatigue Among Patients With Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: The First Report From Iran, Multiple Sclerosis and Related Disorders (2018)
215. Comparison Effect of Prescription Drugs on the Occurrence and the Number of Attacks in Patients With Multiple Sclerosis, Journal of Isfahan Medical School (2018)
216. Cutaneous Anaplastic Large Cell Lymphoma in a Multiple Sclerosis Patient Receiving Fingolimod, Multiple Sclerosis and Related Disorders (2018)
217. Decreased Serum Levels of Interleukin-35 Among Multiple Sclerosis Patients May Be Related to Disease Progression, Journal of Biological Regulators and Homeostatic Agents (2018)
218. Genetic Variation in Intergenic and Exonic Mirna Sequence and Risk of Multiple Sclerosis in the Isfahan Patients, Iranian Journal of Allergy, Asthma and Immunology (2018)
219. High Frequency of Tc22 and Th22 Cells in Myasthenia Gravis Patients and Their Significant Reduction After Thymectomy, NeuroImmunoModulation (2018)
220. High Frequency of Tc22 and Th22 Cells in Myasthenia Gravis Patients and Their Significant Reduction After Thymectomy, NeuroImmunoModulation (2018)
221. Immune Thrombocytopenia (Itp) in a Patient With Relapsing-Remitting Multiple Sclerosis (Rrms) Associated With B-Interferon-1Α Treatment, Indian Journal of Pharmaceutical Education and Research (2018)
222. Increased Proportion of Tc17 and Th17 Cells and Their Significant Reduction After Thymectomy May Be Related to Disease Progression in Myasthenia Gravis, NeuroImmunoModulation (2018)
223. Increased Proportion of Tc17 and Th17 Cells and Their Significant Reduction After Thymectomy May Be Related to Disease Progression in Myasthenia Gravis, NeuroImmunoModulation (2018)
224. Long-Term Disability Trajectories in Primary Progressive Ms Patients: A Latent Class Growth Analysis, Multiple Sclerosis Journal (2018)
225. Lower Extremity Deep Venous Thrombosis in a Multiple Sclerosis Patient on Dimethyl Fumarate, Multiple Sclerosis and Related Disorders (2018)
226. Neuromyelitis Optica Spectrum Disorder and Menstruation, Revue Neurologique (2018)
227. Ox40 Gene and Serum Protein Expression Profiles in Patients With Parkinson's Disease, Cell Journal (2018)
228. Ox40 Gene Expression and Its Serum Levels in New Cases of Patients With Multiple Sclerosis, Advances in Neuroimmune Biology (2018)
229. Phase Sensitive Reconstruction of T1-Weighted Inversion Recovery in the Evaluation of the Cervical Cord Lesions in Multiple Sclerosis; Is It Similarly Eligible in 1.5 T Magnet Fields?, Multiple Sclerosis and Related Disorders (2018)
230. Primary Progressive Multiple Sclerosis in Iran: A Consensus Recommendation for Diagnosis and Management, Multiple Sclerosis and Related Disorders (2018)
231. Primary Progressive Multiple Sclerosis in Iran: A Consensus Recommendation for Diagnosis and Management, Multiple Sclerosis and Related Disorders (2018)
232. Promising Effect of Rapamycin on Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2018)
233. Stability of Mental Toughness, Sleep Disturbances, and Physical Activity in Patients With Multiple Sclerosis (Ms)-A Longitudinal and Pilot Study, Frontiers in Psychiatry (2018)
234. The Interplay of Multiple Sclerosis and Menstrual Cycle: Which One Affects the Other One?, Multiple Sclerosis and Related Disorders (2018)
235. Cerebrospinal Fluid and Serum Markers of Inflammation in Patients With Multiple Sclerosis, Advances in Neuroimmune Biology (2017)
236. Comparison of the Efficacy of Azathioprine and Rituximab in Neuromyelitis Optica Spectrum Disorder: A Randomized Clinical Trial, Journal of Neurology (2017)
237. Contribution of Different Relapse Phenotypes to Disability in Multiple Sclerosis, Multiple Sclerosis (2017)
238. Diagnosis and Management of Neuromyelitis Optica Spectrum Disorder (Nmosd) in Iran: A Consensus Guideline and Recommendations, Multiple Sclerosis and Related Disorders (2017)
239. Diagnosis and Management of Neuromyelitis Optica Spectrum Disorder (Nmosd) in Iran: A Consensus Guideline and Recommendations, Multiple Sclerosis and Related Disorders (2017)
240. Evaluating the Effect of Adding Fish Oil to Fingolimod on Tnf-Α Il1β Il6, and Ifn-Γ in Patients With Relapsing-Remitting Multiple Sclerosis: A Double-Blind Randomized Placebo-Controlled Trial, Clinical Neurology and Neurosurgery (2017)
241. Multiple Sclerosis and Environmental Risk Factors: A Case-Control Study in Iran, Neurological Sciences (2017)
242. Neuromyelitis Optica Spectrum Disease Characteristics in Isfahan, Iran: A Cross-Sectional Study, Journal of Research in Medical Sciences (2017)
243. Prognostic Indicators in Pediatric Clinically Isolated Syndrome, Annals of Neurology (2017)
244. The Effect of Emotional Intelligence Training on Self-Efficacy in Women With Multiple Sclerosis, Iranian Journal of Nursing and Midwifery Research (2017)
245. Towards Personalized Therapy for Multiple Sclerosis: Prediction of Individual Treatment Response, Brain (2017)
246. A Comparison of the Effects of Reflexology and Relaxation on Pain in Women With Multiple Sclerosis, Journal of Complementary and Integrative Medicine (2016)
247. Consanguinity and Multiple Sclerosis Susceptibility: A Case Control Study, Multiple Sclerosis and Related Disorders (2016)
248. Higher Latitude Is Significantly Associated With an Earlier Age of Disease Onset in Multiple Sclerosis, Journal of Neurology, Neurosurgery and Psychiatry (2016)
249. Iranian Consensus on Use of Vitamin D in Patients With Multiple Sclerosis, BMC Neurology (2016)
250. Iranian Consensus on Use of Vitamin D in Patients With Multiple Sclerosis, BMC Neurology (2016)
251. Mental Toughness, Sleep Disturbances, and Physical Activity in Patients With Multiple Sclerosis Compared to Healthy Adolescents and Young Adults, Neuropsychiatric Disease and Treatment (2016)
252. Risk Factors of Multiple Sclerosis and Their Relation With Disease Severity: A Cross-Sectional Study From Iran, Archives of Iranian Medicine (2016)
253. Serum Ox40 Level in Patients With Neuromyelitis Optica, Journal of Isfahan Medical School (2016)
254. A Double-Blind, Placebo-Controlled Trial of Adding Erythropoietin to Intravenous Methylprednisolone for the Treatment of Unilateral Acute Optic Neuritis of Unknown or Demyelinative Origin, Graefe's Archive for Clinical and Experimental Ophthalmology (2015)
255. A Double-Blind, Placebo-Controlled Trial of Adding Erythropoietin to Intravenous Methylprednisolone for the Treatment of Unilateral Acute Optic Neuritis of Unknown or Demyelinative Origin, Graefe's Archive for Clinical and Experimental Ophthalmology (2015)
256. Bremso: A Simple Score to Predict Early the Natural Course of Multiple Sclerosis, European Journal of Neurology (2015)
257. Comparing the Effects of Memantine and Sodium Valproate in Prevention of Chronic and Episodic Migraine, Journal of Isfahan Medical School (2015)
258. Comparing the Effects of Reflexology and Relaxation on Fatigue in Women With Multiple Sclerosis, Iranian Journal of Nursing and Midwifery Research (2015)
259. Cytokine Gene Expression in Newly Diagnosed Multiple Sclerosis Patients, Iranian Journal of Allergy, Asthma and Immunology (2015)
260. Depression and Cognitive Performances in Patients With Multiple Sclerosis, Journal of Isfahan Medical School (2015)
261. Male Sex Is Independently Associated With Faster Disability Accumulation in Relapse-Onset Ms But Not in Primary Progressive Ms, PLoS ONE (2015)
262. Psychological Well-Being in People With Multiple Sclerosis in an Iranian Population, Journal of Research in Medical Sciences (2015)
263. The Effect of Plasma Exchange on the Expression of Foxp3 and Rorc2 in Relapsed Multiple Sclerosis Patients, Iranian Journal of Immunology (2015)
264. A Single-Subject Study to Examine the Effects of Constrained-Induced Aphasia Therapy on Naming Deficit, International Journal of Preventive Medicine (2014)
265. Correlation of Midkine Serum Level With Pro- and Anti-Inflamatory Cytokines in Multiple Sclerosis, Iranian Journal of Immunology (2014)
266. Islamic Fasting and Multiple Sclerosis, BMC Neurology (2014)
267. Preventive Effects of a Three-Month Yoga Intervention on Endothelial Function in Patients With Migraine, International Journal of Preventive Medicine (2014)
268. The Effects of Intradermal Botulinum Toxin Type a Injections on Pain Symptoms of Patients With Diabetic Neuropathy, Journal of Research in Medical Sciences (2014)
269. Toll Like Receptor 2 and 4 Expression in Peripheral Blood Mononuclear Cells of Multiple Sclerosis Patients, Iranian Journal of Immunology (2014)
270. Vitamin D Supplementation Could Limit T Helper-17 Response in Multiple Sclerosis, Clinical and Experimental Neuroimmunology (2014)
271. A Literature Review on the Efficacy and Safety of Botulinum Toxin: An Injection in Post-Stroke Spasticity, International Journal of Preventive Medicine (2013)
272. Antibodies to Interferon Beta in Patients With Multiple Sclerosis Receiving Cinnovex, Rebif, and Betaferon, Journal of Korean Medical Science (2013)
273. Biased Treg/Th17 Balance Away From Regulatory Toward Inflammatory Phenotype in Relapsed Multiple Sclerosis and Its Correlation With Severity of Symptoms, Journal of Neuroimmunology (2013)
274. Brain Radiation and Possible Presentation of Multiple Sclerosis, Journal of Research in Medical Sciences (2013)
275. Can Vitamin D Suppress Endothelial Cells Apoptosis in Multiple Sclerosis Patients?, International Journal of Preventive Medicine (2013)
276. Comparison of the Effect of Baclofen and Transcutaneous Electrical Nerve Stimulation for the Treatment of Spasticity in Multiple Sclerosis, Neurological Research (2013)
277. Evaluation of Neural Gene Expression in Serum Treated Embryonic Stem Cells in Alzheimer's Patients, Journal of Research in Medical Sciences (2013)
278. Multiple Sclerosis in Sistan and Baloochestan, South East Iran, Clinical Neurology and Neurosurgery (2013)
279. Olanzapine Versus Haloperidol: Which Can Control Stuttering Better?, International Journal of Preventive Medicine (2013)
280. Oral Prednisolone in the Treatment of Cervical Radiculopathy: A Randomized Placebo Controlled Trial, Journal of Research in Medical Sciences (2013)
281. Preliminary Investigation of Economics Issues in Hospitalized Patients With Stroke, International Journal of Preventive Medicine (2013)
282. Restless Legs Syndrome in Iranian Multiple Sclerosis Patients: A Case-Control Study, International Journal of Preventive Medicine (2013)
283. Seizure Characteristics in Multiple Sclerosis Patients, Journal of Research in Medical Sciences (2013)
284. Seizure in Iranian Patients With Multiple Sclerosis, Journal of Research in Medical Sciences (2013)
285. Sex As a Determinant of Relapse Incidence and Progressive Course of Multiple Sclerosis, Brain (2013)
286. Short-Term Safety of Pulse Steroid Therapy in Multiple Sclerosis Relapses, Clinical Neuropharmacology (2013)
287. Stem Cell Therapy in Stroke: A Review Literature, International Journal of Preventive Medicine (2013)
288. Study of Type a and B Behavior Patterns in Patients With Multiple Sclerosis in an Iranian Population, International Journal of Preventive Medicine (2013)
289. The Comparative Analysis of Serum Levels of Midkine in Patients With Multiple Sclerosis and Control Group, Journal of Isfahan Medical School (2013)
290. The Effect of Pioglitazone on the Alzheimer’S Disease-Induced Apoptosis in Human Umbilical Vein Endothelial Cells, International Journal of Preventive Medicine (2013)
291. The Psychometric Properties of the Persian Migraine-Specific Quality of Life Questionnaire Version 2.1 in Episodic and Chronic Migraines, The Scientific World Journal (2013)
292. The Relation Between Vitamin D Status With Fatigue and Depressive Symptoms of Multiple Sclerosis, Journal of Research in Medical Sciences (2013)
293. The Value of Provocative Tests in Diagnosis of Cervical Radiculopathy, Journal of Research in Medical Sciences (2013)
294. Color Blindness Among Multiple Sclerosis Patients in Isfahan, Journal of Research in Medical Sciences (2012)
295. Comparison of the Effect of Aspirin and Amantadine for the Treatment of Fatigue in Multiple Sclerosis: A Randomized, Blinded, Crossover Study, Neurological Research (2012)
296. Designing of an Elisa Method for the Measurement of Serum Antibodies Against Interferon-Beta and the Study of the Frequency of These Antibodies in Patients With Multiple Sclerosis Treated With Cinnovex, Journal of Isfahan Medical School (2012)
297. Interferon-Beta in Pediatric Multiple Sclerosis Patients: Safety in Short-Term Prescription, Acta Medica Iranica (2012)
298. Is the Iranian Revolution to Blame for the Increasing Incidence of Multiple Sclerosis in Iran?, Neuroepidemiology (2012)
299. The Frequency of Cognitive Dysfunction Among Multiple Sclerosis Patients With Mild Physical Disability, Journal of Isfahan Medical School (2012)
300. The Kurtzke Edss Rank Stability Increases 4 Years After the Onset of Multiple Sclerosis: Results From the Msbase Registry, Journal of Neurology, Neurosurgery and Psychiatry (2012)
301. Is Chiari Malformation a Cause of Systemic Hypertension and Sinus Bradycardia? a Case Report and Literature Review, Journal of Research in Medical Sciences (2011)
302. Myasthenia Gravis As a Presenting Feature in a Patient With Lung Cancer: A Case Report, Journal of Research in Medical Sciences (2011)
303. Prevalence of Familial Multiple Sclerosis in Isfahan, Iran, Journal of Isfahan Medical School (2011)
304. The Value of Provocative Tests in Diagnosis of Acute and Chronic Cervical Radiculopathy, Journal of Isfahan Medical School (2011)
305. A Comparative Study of 25 (Oh) Vitamin D Serum Levels in Patients With Multiple Sclerosis and Control Group in Isfahan, Iran, International Journal of Preventive Medicine (2010)
306. Does Early-Onset Multiple Sclerosis Differ From Adult-Onset Form in Iranian People, Journal of Research in Medical Sciences (2010)
307. Effects of Adjunct Glucosamine Sulfate on Relapsing-Remitting Multiple Sclerosis Progression: Preliminary Findings of a Randomized, Placebo-Controlled Trial, Neurological Research (2010)
308. Does Amantadine Have Favourable Effects on Fatigue in Persian Patients Suffering From Multiple Sclerosis?, Neurologia i Neurochirurgia Polska (2009)
309. Reply, Journal of Research in Medical Sciences (2009)
310. Sensory Complaints of the Upper Extremities in Multiple Sclerosis: Relative Efficacy of Nortriptyline and Transcutaneous Electrical Nerve Stimulation, Clinical Journal of Pain (2009)
311. Short-Term Effects of Prolonged Fasting on Multiple Sclerosis, European Neurology (2009)
312. A Double-Blind, Randomized Trial of Low-Dose Topiramate Vs Propranolol in Migraine Prophylaxis, Acta Neurologica Scandinavica (2008)
313. Effects of Rivastigmine on Memory and Cognition in Multiple Sclerosis, Canadian Journal of Neurological Sciences (2008)
314. Hoarseness, a Major Presenting Symptom in a Patient With Multiple Sclerosis, Journal of Research in Medical Sciences (2008)
315. Relationship Between Helicobacter Pylori Immunoglobulin G Antibody and Thrombotic Ischemic Stroke, Acta Medica Iranica (2008)
316. A Rare Case of Sporadic Creutzfeldt-Jakob Disease in Isfahan, Iran, Journal of Research in Medical Sciences (2007)
317. Association Between Chlamydia Pneumoniae Infection and Carotid Atherosclerotic Plaques, Journal of Research in Medical Sciences (2007)
318. Chlamydia Pneumoniae Infection and Thrombotic Ischemic Stroke, Journal of Isfahan Medical School (2007)
319. Comparison of Interferon Beta Products and Azathioprine in the Treatment of Relapsing-Remitting Multiple Sclerosis, Journal of Neurology (2007)
320. Conjugal Multiple Sclerosis in Isfahan, Iran: A Population-Based Study, Multiple Sclerosis (2007)
321. Comparison of Betaferon, Avonex, and Rebif in Treatment of Relapsing-Remitting Multiple Sclerosis, Acta Neurologica Scandinavica (2006)
322. Comparison of the Effect of Topiramate and Sodium Valporate in Migraine Prevention: A Randomized Blinded Crossover Study, Headache (2006)
323. Prevalence of Multiple Sclerosis in Isfahan, Iran, Neuroepidemiology (2006)
324. Serum Homocysteine Level in Patients With Multiple Sclerosis, Journal of Research in Medical Sciences (2005)